In the Results section of this Article, haematoxylin and eosin staining data from the TCGA repository are incorrectly referred to as immunohistochemistry data. All references to ‘immunohistochemistry’ or ‘IHC’ should read ‘haematoxylin and eosin staining’ or ‘H&E staining’, respectively.
Additional information
The online version of the original article can be found at 10.1038/ncomms9971
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Aran, D., Sirota, M. & Butte, A. Correction: Corrigendum: Systematic pan-cancer analysis of tumour purity. Nat Commun 7, 10707 (2016). https://doi.org/10.1038/ncomms10707
Published:
DOI: https://doi.org/10.1038/ncomms10707
This article is cited by
-
Optimized risk stratification strategy for glioma patients based on the feature genes of poor immune cell infiltration patterns
Journal of Cancer Research and Clinical Oncology (2023)
-
A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker
Cancer Cell International (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.